Earlier this month, executives, scientists and health policy and government affairs professionals joined us at +Dx Forum for a day of learning and networking about the latest regulatory and reimbursement developments impacting laboratory diagnostics.
Rachel Stauffer, Amy Kelbick and Paul Radensky recap their top takeaways from the conference and look ahead to the biggest issues facing diagnostics in the year to come.
